Marc Barritault

12PUBLICATIONS
146CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCentral nervous systemPsychological methodology, design and analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 07, 2026
New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.

|Jun 27, 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.

Aurelien Maureille, Enora Vauleon, David Meyronet

|Jan 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology.

Clémence Deligne, Arthur Tourbez, Flavie Bénard

|Dec 03, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle

|Nov 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).

Thomas Walter, Thierry Lecomte, Julien Hadoux

|Jun 10, 2024
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.

Ines Esparragosa Vazquez, Marc Sanson, Olivier L Chinot

Pageof 2

Frequent Collaborators

5 joint publications

David Meyronet

4 joint publications

Pierre Leblond

3 joint publications

François Ducray

2 joint publications

Thiébaud Picart